赛诺医疗收盘上涨1.66%，滚动市盈率2503.41倍，总市值38.08亿元

Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Sino Medical, indicating a significant disparity between its high PE ratio and the industry average [1][2] - As of April 10, Sino Medical's closing price was 9.21 yuan, with a PE ratio of 2503.41, significantly higher than the industry average of 46.15 [1][2] - The company's total market capitalization stands at 3.808 billion yuan, ranking it 121st in the medical device industry [1][2] Group 2 - Sino Medical specializes in the research, production, and sales of high-end interventional medical devices, with its main products being coronary stent systems and balloon dilation catheters [1] - The latest financial report for Q3 2024 shows a revenue of 318 million yuan, representing a year-on-year increase of 30.20%, while the net profit was a loss of approximately 6.74 million yuan, a year-on-year decline of 83.84% [1] - The gross profit margin for the company is reported at 61.29% [1]